...
首页> 外文期刊>American Journal of Nephrology >Acute responses of gastrointestinal hormones to both oral and parenteral intradialytic nutrition.
【24h】

Acute responses of gastrointestinal hormones to both oral and parenteral intradialytic nutrition.

机译:胃肠激素对口服和肠胃外透析营养的急性反应。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Intradialytic nutrition (IDN) has been used to improve the nutritional status of malnourished hemodialysis (HD) patients. OBJECTIVE: To evaluate the different effects of parenteral IDN (IDPN) and oral IDN (IDON) on nutrition-related gastrointestinal hormones. PATIENTS AND METHODS: Seven clinically stable HD patients with malnutrition were included. All patients were treated for 1 month with either IDPN or IDON, with a 4-week period of no nutritional support between each type of therapy. On the first day of each nutritional support (IDON or IDPN) we analyzed the acute responses of insulin, ghrelin, and glucagon-like peptide 1 (GLP-1). We compared the areas under the secretory curves (AUC) and the maximum peaks of serum glucose, insulin, ghrelin, and GLP-1. A group of 6 clinically stable HD patients without any type of IDN served as the control group. RESULTS: The acute responses of glucose and insulin to IDN were significantly higher with IDPN than with IDON. The AUC of glucose (602 +/- 81 vs. 495 +/- 81 mg/dl/h, p < 0.01) and insulin (232 +/- 103 vs. 73.8 +/- 69 muU/ml/h, p < 0.01) as well as the maximum peaks of glucose (228 +/- 41 vs. 177 +/- 47 mg/dl, p < 0.05) and insulin (104 +/- 46 vs. 29 +/- 24 muU/ml, p < 0.01) were significantly higher after IDPN than after IDON. Ghrelin decreased after both IDPN and IDON; however, the decrease was significantly higher with IDPN compared to IDON. The ghrelin nadir was significantly lower in IDPN than in IDON (0.77 +/- 0.5 vs. 1.5 +/- 0.3, p < 0.05) although the AUC of ghrelin was not significantly different. GLP-1 was significantly increased at 1 h after starting both IDPN and IDON with no significant differences between the groups. CONCLUSION: IDPN induces a higher increase in serum glucose and insulin levels and a greater reduction in serum ghrelin concentrations compared with an equivalent orally administered nutritional supplement.
机译:简介:透析内营养(IDN)已用于改善营养不良性血液透析(HD)患者的营养状况。目的:评估肠胃外IDN(IDPN)和口服IDN(IDON)对营养相关胃肠激素的不同作用。患者与方法:纳入7例临床稳定的HD营养不良患者。所有患者均接受IDPN或IDON治疗1个月,每种治疗之间有4周无营养支持。在每种营养支持(IDON或IDPN)的第一天,我们分析了胰岛素,生长激素释放肽和胰高血糖素样肽1(GLP-1)的急性反应。我们比较了分泌曲线(AUC)下的面积和血清葡萄糖,胰岛素,生长素释放肽和GLP-1的最大峰。一组6名无任何IDN的临床稳定的HD患者作为对照组。结果:IDPN的葡萄糖和胰岛素对IDN的急性反应显着高于IDON。葡萄糖(602 +/- 81 vs. 495 +/- 81 mg / dl / h,p <0.01)和胰岛素(232 +/- 103 vs. 73.8 +/- 69 muU / ml / h,p <0.01) 0.01)以及葡萄糖(228 +/- 41 vs. 177 +/- 47 mg / dl,p <0.05)和胰岛素(104 +/- 46 vs. 29 +/- 24 muU / ml, p <0.01)在IDPN后显着高于IDON后。 IDPN和IDON均降低后,Ghrelin下降;但是,与IDON相比,IDPN的下降幅度明显更高。尽管ghrelin的AUC没有显着差异,但IDPN中的ghrelin最低值显着低于IDON(0.77 +/- 0.5与1.5 +/- 0.3,p <0.05)。开始IDPN和IDON后1小时,GLP-1明显增加,两组之间无显着差异。结论:与同等的口服营养补充品相比,IDPN引起更高的血清葡萄糖和胰岛素水平增加和更大的血清生长素释放肽浓度降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号